Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: Behavioral and anatomical consequences

Experimental Neurology

Volumn 140, Issue 2, 1996, Pages 126-138

  Winn, Shelley R ^a   Lindner, Mark D ^a   Lee, Alice ^a   Haggett, Gwen ^a   Francis, Jonathan M ^a   Emerich, Dwaine F ^a  

^a CytoTherapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN VENTRICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HAMSTER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030222212     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0123     Document Type: Article

References (45)

1. 1. AEBISCHER, P., S. R. WINN, AND P. M. GALLETTI. 1988. Transplantation of neural tissue in polymer capsules. Brain Res. 448: 364-368.
2. 2. AEBISCHER, P., P. A. TRESCO, S. R. WINN, L. A. GREENE, AND C. B. JAEGER. 1991. Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp. Neurol. 111: 269-275.
3. 3. ALLEN, S. J., D. DAWBARN, AND G. K. WILCOCK. 1988. Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease. Brain Res. 454: 275-281.
4. 4. ARENDT, T., V. BIGL, A. ARENDT, AND A. TENNSTEDT. 1983. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans, and Korsakof's disease. Acta Neuropathol. 61: 101-108.
5. 5. BARTUS, R., R. L. DEAN, C. BEER, AND A. S. LIPA. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417.
6. 6. BLIN, N., AND D. W. STAFFORD. 1976. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3: 2303.
7. 7. BREAKEFIELD, X. O. 1989. Combining CNS transplantation and gene transfer. Neurobiol. Aging 10: 647-648.
8. 8. CANDY, J. M., R. H. PERRY, E. K. PERRY, D. IRVING, G. BLESSED, A. F. FAIRBAIRN, AND B. E. TOMLINSON. 1983. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J. Neurol. Sci. 59: 277-289.
9. 9. CAVICCHIOLI, L., T. P. FLANIGAN, J. G. DICKSON, G. VANTINI, R. D. TOSO, M. FUSCO, F. S. WALSH, AND A. LEON. 1991. Mol. Brain Res. 9: 319-325.
10. 10. CHEN, K. S., AND F. H. GAGE. 1994. Somatic gene transfer of NGF to the aged brain: Behavioral and morphological amelioration. J. Neurosci. 15(4): 2819-2825.
11. 11. COHEN, J. 1988. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates, Inc., Hillsdale, New Jersey.
12. 12. COYLE, J. T., D. H. PRICE, AND M. R. DELONG. 1983. Alzheimer's disease: A disorder or cortical cholinergic innervation. Science 219: 1184-1189.
13. 13. DEKKER, A. J., J. WINKLER, J. RAY, L. J. THAL, AND F. H. GAGE. 1994. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience 60(2): 299-309.
14. 14. DODD, D. H., AND R. F. SCHULTZ, JR. 1973. Computational procedures for estimating magnitude of effect for some analysis of variance designs. Psychol. Bull. 79(6): 391-395.
15. 15. DUNNETT, S. B. 1985. Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology (Berl) 87: 357-363.
16. 16. EMERICH, D. F., B. R. FRYDEL, T. R. FLANAGAN, M. PALMITIER, S. R. WINN, AND L. CHRISTENSON. 1993. Transplantation of polymer encapsulated PC12 cells: use of chitosan as an immobilization matrix. Cell Trans. 2: 241-249.
17. 17. EMERICH, D. F., S. R. WINN, J. HARPER, J. P. HAMMANG, E. E. BAETGE, AND J. H. KORDOWER. 1994. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons. J. Comp. Neurol. 349: 148-164.
18. 18. ERNFORS, P., T. EBENDAL, L. OLSON, P. MOUTON, I. STRÖMBERG, AND H. PERSSON. 1989. A cell line producing recombinant nerve growth factor evokes growth responses in intrinsic and grafted central cholinergic neurons. Proc. Natl. Acad. Sci. USA 86: 4756-4760.
19. 19. FISCHER, W., K. WICTORIN, A. BJÖRKLUND, L. R. WILLIAMS, S. VARON, AND F. H. GAGE. 1987. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329: 65-68.
20. 20. FRIM, D. M., J. SIMPSON, T. A. UHLER, M. P. SHORT, S. R. BOSSI, X. O. BREAKEFIELD, AND O. ISACSON. 1992. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35: 452-458.
21. 21. GAGE, F. H., J. A. WOLFF, M. B. ROSENBERG, L. XU, AND J. K. YEE. 1987. Grafting genetically modified cells to the brain: Possibilities for the future. Neuroscience 23: 795-807.
22. 22. HEDREEN, J. C., S. J. BACON, AND D. L. PRICE. 1985. A modified histochemical technique to visualize acetylcholinesterase-containing axons. J. Histochem. Cytochem. 33: 134-140.
23. 23. HEFTI, F. 1986. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6: 2155-2162.
24. 24. HOFFMAN, D., X. O. BREAKEFIELD, M. P. SHORT, AND P. AEBISCHER. 1993. Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp. Neurol. 122: 100-106.
25. 25. KAWAJA, M. D., M. B. ROSENBERG, K. YOSHIDA, AND F. H. GAGE. 1992. Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J. Neurosci. 12: 2849-2864.
26. 26. KOLIATSOS, V. E., R. E. CLATTERBUCK, H. J. W. NAUTA, B. KNUSEL, L. E. BURTON, F. HEFTI, W. C. MOBLEY, AND D. L. PRICE. 1991. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann. Neurol. 30: 831-840.
27. 27. KORDOWER, J. H., S. R. WINN, Y. T. LIU, E. J. MUFSON, J. R. SLADEK, JR., J. P. HAMMANG, E. E. BAETGE, AND D. F. EMERICH. 1994. The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons following grafts of encapsulated human NGF-secreting cells. Proc. Natl. Acad. Sci. USA 91: 10898-10902.
28. 28. KORDOWER, J. H., E.-Y. CHEN, E. J. MUFSON, S. R. WINN, AND D. F. EMERICH. 1996. Intrastriatal implants of polymer-encapsulated cells genetically modified to secrete human NGF:Tropic effects upon cholinergic and noncholinergic neurons. Neuroscience, in press.
29. 29. KROMER, L. F. 1987. Nerve growth factor treatment after brain injury prevents neuronal death. Science 235: 214-216.
30. 30. LINDNER, M. D., AND V. K. GRIBKOFF. 1991. Relationship between performance in the Morris water task, visual acuity, and thermoregulatory function in aged F-344 rats. Behav. Brain Res. 45: 45-55.
31. 31. LINDNER, M. D., S. I. DWORETZKY, C. SAMPSON, AND R. LOY. 1994. Relationship of APP mRNA transcripts and levels of NGF and low-affinity NGF receptors to Behavioral Measures of Age-Related Cognitive Dysfunction. J. Neurosci. 14: 2282-2289.
32. 32. LINDNER, M. D., C. E. KEARNS, S. R. WINN, B. FRYDEL, AND D. F. EMERICH. 1996. Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. Cell Trans. 5(2): 205-223.
33. 33. MARKOWSKA, A. L., V. E. KOLIATSOS, S. J. BRECKLER, D. L. PRICE, AND D. S. OLTON. 1994. Human nerve growth factor improves spatial memory in aged by not in young rats. J. Neurosci. 14: 4815-4824.
34. 34. MAYSINGER, D., P. PICCARDO, M. GOINY, AND A. C. CUELLO. 1992. Grafting of genetically modified cells: Effects of acetylcholine release in vivo. Neurochem. Inter. 21: 543-548.
35. 35. OLSON, L., A. NORDBERG, H. VON HOLST, L. BACKMAN, T. EBENDAL, I. ALAFUZOFF, K. AMBERLA, P. HARTVIG, A. HERLITZ, A. LILJA, H. LUNDQVIST, B. LANGSTROM, B. MEYERSON, A. PERSSON, M. VLITANEN, B. WINBLAD, AND A. SEIGER. 1992. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J. Neur. Trans. (P.-D. Sect.) 4: 79-495.
36. 36. PAULE, M. G. 1994. Analysis of Brain Function Using a Battery of Schedule-Controlled Operant Behaviors. In Neurobehavioral Toxicity: Analysis and Interpretation (B. Weiss and J. L. Odonoghue, Eds.), pp. 331-338. Raven Press, NY.
37. 37. ROSENBERG, M. B., T. FRIEDMAN, R. C. ROBERTSON, M. H. TUSZYNSKI, J. A. WOLFF, X. O. BREAKEFIELD, AND F. H. GAGE. 1988. Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science 242: 1575-1578.
38. 38. SAS INSTITUTE INC. 1989. SAS/STAT User's Guide, Version 6, Fourth Edition, Volume 1. Cary, North Carolina: SAS Institute Inc.
39. 39. SCHUMACHER, J. M., M. P. SHORT, B. T. HYMAN, X. O. BREAKEFIELD, AND O. ISACSON. 1991. Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 45: 561-570.
40. 40. STRÖMBERG, I., C. J. WETMORE, T. EBENDAL, P. ERNFORS, H. PERSSON, AND L. OLSON. 1990. Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J. Neurosci. Res. 25: 405-411.
41. 41. TUSZYNSKI, M. H., U. HS, K. YOSHIDA, AND F. H. GAGE. 1991. Recombinant human nerve factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann. Neurol. 30: 625-636.
42. 42. WHITEHOUSE, P. J., D. L. PRICE, R. G. STRUBLE, A. W. CLARKE, J. T. COYLE, AND M. R. BELONG. 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237-1239.
43. 43. WILLIAMS, L. R., S. VARON, G. M. PETERSON, K. WICTORIN, W. FISCHER, A. BJÖRKLUND, AND F. H. GAGE. 1986. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. USA 83: 9231-9235.
44. 44. WINN, S. R., P. A. TRESCO, B. ZIELINSKI, L. A. GREENE, C. B. JAEGER, AND P. AEBISCHER. 1991. Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp. Neurol. 113: 322-329.
45. 45. WINN, S. R., J. P. HAMMANG, D. F. EMERICH, A. LEE, R. D. PALMITER, AND E. E. BAETGE. 1994. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. Natl. Acad. Sci. USA 91: 2324-2328.